ロード中...
A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined with Paclitaxel and Pegfilgrastim: A Feasibility Study in Patients with Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
PURPOSE: Dose-dense regimens have been shown to improve outcome when given as adjuvant therapy to patients with breast cancer compared with their three weekly counterparts. We investigated the feasibility of a dose-dense regimen with carboplatin/paclitaxel followed by pegfilgrastim in patients with...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2918716/ https://ncbi.nlm.nih.gov/pubmed/20547415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2010.05.020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|